Dobutamine Stress Echocardiography: Protocol, Indications, and Interpretation of Contractility Disorders — МЕДТРЕЙН Asia
Echocardiography

Dobutamine Stress Echocardiography: Protocol, Indications, and Interpretation of Contractility Disorders

Briefly. Dobutamine Stress Echocardiography (DSE) is used to assess coronary artery disease (CAD) and to clarify the severity of aortic stenosis (AS) in the presence of left ventricular (LV) dysfunction. For AS, a low-dose protocol is used: starting at 2.5 or 5 mcg/kg/min with increments every 3–5 minutes up to 10–20 mcg/kg/min under medical supervision due to the risk of arrhythmias (EACVI/ASE, 2017).

Indications

According to ASE guidelines (2020), stress imaging tests, including stress echocardiography, are indicated for patients suspected of CAD with resting ECG changes that hinder accurate interpretation of exercise-induced ECG changes. In patients with left bundle branch block (LBBB) and symptoms consistent with CAD, stress echocardiography (ESE or DSE) is preferred over SPECT imaging due to its greater specificity and versatility in detecting other heart diseases associated with LBBB.

A specific indication is the clarification of the severity of aortic stenosis in the context of LV dysfunction, where a low-dose dobutamine protocol is applied (EACVI/ASE, 2017).

Protocol for Aortic Stenosis with LV Dysfunction

According to EACVI/ASE guidelines (2017), a low-dose protocol is used to assess the severity of AS in the context of LV dysfunction.

ParameterValue
Starting Dose2.5 or 5 mcg/kg/min
Increment Stepevery 3–5 minutes
Maximum Dose10–20 mcg/kg/min

Due to the risk of arrhythmias, medical supervision is mandatory; high doses of dobutamine should be avoided.

Interpretation of Contractility Disorders

Myocardial strain analysis during dobutamine stress echocardiography is discussed in the ASE/EACVI consensus on strain echocardiography (2024). Signs of critical myocardial ischemia in flow-limiting coronary stenosis include subendocardial wall thickening impairment and postsystolic shortening. Both 2D speckle-tracking and tissue Doppler are used to assess strain during DSE [specific threshold values to be clarified].

Limitations in Other Conditions

In hypertrophic cardiomyopathy (Culshaw C.M. et al., 2025), dobutamine infusion is not used as it increases Doppler velocities in the outflow tract even in normal hearts; exercise stress echocardiography (treadmill or bicycle ergometer) is used if necessary. Stress echocardiography is not recommended for routine monitoring during mavacamten therapy.

Frequently asked questions

Can dobutamine be used in HCM?

No. Dobutamine infusion is not used in HCM as it increases Doppler velocities in the outflow tract even in normal hearts; exercise stress echocardiography on a treadmill or bicycle ergometer is used (Culshaw et al., 2025).

What is the starting and maximum dose level of dobutamine for assessing AS with LV dysfunction?

Start at 2.5 or 5 mcg/kg/min with increments every 3–5 minutes up to a maximum dose of 10–20 mcg/kg/min (EACVI/ASE, 2017).

When is DSE preferred over SPECT?

In patients with LBBB and symptoms consistent with CAD, stress echocardiography (ESE or DSE) is preferred over SPECT due to its greater specificity and versatility in detecting other heart diseases associated with LBBB (ASE, 2020).

What echo signs indicate critical ischemia during DSE?

Subendocardial wall thickening impairment and postsystolic shortening are signs of critical myocardial ischemia in flow-limiting coronary stenosis (ASE/EACVI, 2024).

Is stress echocardiography needed during mavacamten therapy?

No, stress echocardiography is not recommended for routine monitoring during mavacamten therapy; monitoring of LV function is mandatory (Culshaw et al., 2025).

The material is intended for specialists and does not replace clinical judgment. Threshold values are periodically reviewed — refer to the current edition of the applicable consensus.
Sources: Baumgartner H. et al. Echocardiographic Assessment of Aortic Stenosis: EACVI/ASE Focused Update, 2017; Pellikka P.A. et al. Guidelines for Performance, Interpretation, and Application of Stress Echocardiography in Ischemic Heart Disease, ASE, 2020; Clinical Applications of Strain Echocardiography, ASE/EACVI, 2024; Culshaw C.M. et al. Guideline for TTE Assessment of HCM Receiving Myosin-Inhibitor Therapy, 2025.
View specialty courses: Echocardiography →
Спросить Alex Отвечу на любой вопрос · 24/7 · на любом языке